Total planned funding: $155,240,583
Allocations
Countries/Regions
India | $155,240,583 |
Organizational Types
Unknown | $101,815,899 |
Own Agency | $20,167,376 |
NGO | $19,540,500 |
University | $3,600,000 |
Implementing Agency | $3,100,000 |
Private Contractor | $2,409,000 |
Multi-lateral Agency | $2,006,808 |
FBO | $2,000,000 |
Host Country Government Agency | $601,000 |
Other USG Agency | $0 |
Program Areas
Governance and Systems | $61,142,641 |
Prevention | $39,283,878 |
Care | $19,356,740 |
Management and Operations | $16,735,922 |
Testing | $7,795,197 |
Treatment | $6,498,413 |
Budget Codes
OHSS: Health Systems Strengthening | $34,793,475 |
HVSI: Strategic Information | $19,361,231 |
HVOP: Sexual Prevention: Other Sexual Prevention | $18,648,725 |
HVMS: Management and Operations | $16,735,922 |
HBHC: Care: Adult Care and Support | $13,048,246 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $10,239,957 |
HVCT: Testing: HIV Testing and Counseling | $7,795,197 |
HLAB: Laboratory Infrastructure | $6,987,935 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $6,163,432 |
HTXS: Treatment: Adult Treatment | $5,928,872 |
HKID: Care: Orphans and Vulnerable Children | $3,281,093 |
HVTB: Care: TB/HIV | $2,824,672 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $2,361,928 |
HMBL: Biomedical Prevention: Blood Safety | $1,869,836 |
PDTX: Treatment: Pediatric Treatment | $546,064 |
PDCS: Care: Pediatric Care and Support | $202,729 |
HTXD: Treatment: ARV Drugs | $23,477 |
HMIN: Biomedical Prevention: Injection Safety | $0 |
Top Partner Programs
Not Available:
$101,815,899
Countries/Regions
USG Aggregated Agencies:
$15,051,339
Countries/Regions
FHI 360:
$9,973,000
Countries/Regions
University of Washington:
$3,600,000
Countries/Regions